Ongoing studies are expected to provide information about how to sequence cabozantinib in clinical practice.
Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.
Cancer Therapy Advisor interviewed Keith Flaherty, MD, about recent findings regarding targeted therapies for melanoma.
More studies are needed to define the role of intratumoral androgen production and mCRPC resistance to hormonal therapies, and to determine if inhibitors of other steroidogenesis enzymes can be synergistic with abiraterone.
Immune checkpoint inhibitors may be effective for treating elderly patients with melanoma without dramatically increasing toxicity.
Two vaccine therapies, TG4010 and CIMAvax-EGF, show promise for treating lung cancer. Developed and approved for use in Cuba, CIMAvax-EGF is now undergoing clinical study in the United States.
Pembrolizumab may be an effective treatment for patients with a rare subtype of diffuse large B-cell lymphoma, which usually carries a poor prognosis.
Cancer Therapy Advisor asked Dr Rabinowitz, founder and CEO of Natera, about the bespoke PCR technology and ongoing studies.
New immunotherapeutic approaches, such as dendritic cell vaccination, may be effective for treating this rare brain cancer, which is associated with dismal survival rates.
Long-term follow-up data from randomized trials on Hodgkin lymphoma support current risk-adapted therapeutic approaches for early-stage disease.
Nutrition is a critical factor to consider both in the pre- and postoperative period for patients undergoing a Whipple procedure.
According to a study across all 32 cancer types, data suggest that 66% of mutations leading to cancer are the result of random events.
Clinical trials and drug approvals in the past several years have dramatically improved bladder cancer treatment.
More studies are needed to determine the association between periodontal disease and non-Hodgkin lymphoma.
A recent meta-analysis including patients from 7 trials shows that MR improves overall survival among all patients regardless of patient and disease characteristics.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|